Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
33.3%
% of MEDX's 30 holdings also in PJP
40.0%
% of PJP's 25 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 5.9% | 5.0% | 5.0% |
|
ABBVIE INC | 7.8% | 4.9% | 4.9% |
|
JOHNSON & JOHNSON | 4.9% | 5.5% | 4.9% |
|
ELI LILLY & CO | 15.5% | 4.5% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 6.2% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PJP
|
ELI LILLY & CO | 11.0% |
 |
NOVARTIS AG-ADR | 6.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
|
ALNYLAM PHARMACEUTICALS INC | 4.2% |
 |
ALKERMES PLC | 4.0% |
|
CRISPR THERAPEUTICS AG | 3.1% |
|
ABBVIE INC | 2.9% |
|
IONIS PHARMACEUTICALS, INC. | 2.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.3% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
MEDX Underweight Relative to PJP
|
ABBOTT LABORATORIES | -6.0% |
|
CORCEPT THERAPEUTICS INC | -5.1% |
|
GILEAD SCIENCES INC | -3.9% |
|
PACIRA PHARMACEUTICALS INC | -3.9% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.9% |
|
JAZZ PHARMACEUTICALS PLC | -3.6% |
|
LIGAND PHARMACEUTICALS-CL B | -3.6% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
SUPERNUS PHARMACEUTICALS INC | -3.5% |
|
VIATRIS, INC. | -3.5% |